197 related articles for article (PubMed ID: 26423313)
1. Immunopathogenesis of olmesartan-associated enteropathy.
Marietta EV; Nadeau AM; Cartee AK; Singh I; Rishi A; Choung RS; Wu TT; Rubio-Tapia A; Murray JA
Aliment Pharmacol Ther; 2015 Dec; 42(11-12):1303-14. PubMed ID: 26423313
[TBL] [Abstract][Full Text] [Related]
2. An atypical case of chronic diarrhoea: olmesartan-induced sprue-like enteropathy.
Naik DK; Martelli MG; Gonzalo DH; Sharma AK; Pannu D
BMJ Case Rep; 2015 Sep; 2015():. PubMed ID: 26370634
[TBL] [Abstract][Full Text] [Related]
3. A Rare Case of Olmesartan-Associated Enteropathy Successfully Managed With Steroid Taper.
Xue A; Fowler MR; Silverman J; Sturkie E; Raff E
Cureus; 2023 Jul; 15(7):e41604. PubMed ID: 37559845
[TBL] [Abstract][Full Text] [Related]
4. Severe spruelike enteropathy associated with olmesartan.
Rubio-Tapia A; Herman ML; Ludvigsson JF; Kelly DG; Mangan TF; Wu TT; Murray JA
Mayo Clin Proc; 2012 Aug; 87(8):732-8. PubMed ID: 22728033
[TBL] [Abstract][Full Text] [Related]
5. Duodenal Villous Atrophy in a TTG-Negative Patient Taking Olmesartan: A Case Report and Review of the Literature.
Kulai T; Arnason T; MacIntosh D; Igoe J
Can J Gastroenterol Hepatol; 2016; 2016():6091571. PubMed ID: 27446852
[TBL] [Abstract][Full Text] [Related]
6. Systematic review: Sprue-like enteropathy associated with olmesartan.
Ianiro G; Bibbò S; Montalto M; Ricci R; Gasbarrini A; Cammarota G
Aliment Pharmacol Ther; 2014 Jul; 40(1):16-23. PubMed ID: 24805127
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Pharmacodynamics and Celiac Effects of Olmesartan Medoxomil Formulations by using Olmesartan-induced Celiac-rat-model.
Komesli Y; Ergur BU; Karasulu E
Curr Drug Deliv; 2021; 18(10):1515-1525. PubMed ID: 34225629
[TBL] [Abstract][Full Text] [Related]
8. Small bowel enteropathy associated with olmesartan medoxomil treatment.
Galanopoulos M; Varytimiadis L; Tsigaridas A; Karatzas PS; Archavlis E; Viazis N; Vourlakou C; Mantzaris GJ
Ann Gastroenterol; 2017; 30(1):131-133. PubMed ID: 28042253
[TBL] [Abstract][Full Text] [Related]
9. [Acute renal failure secondary to diarrhea due to sprue like-enteropathy associated with olmesartan].
Ulla-Rocha JL; Lopez-Piñeiro S; Puga-Gimenez M
Gastroenterol Hepatol; 2015 Oct; 38(8):514-5. PubMed ID: 25534549
[No Abstract] [Full Text] [Related]
10. How to deal with the occurrence of rare drug-induced adverse events: the example of sprue-like enteropathy induced by olmesartan medoxomil and other angiotensin-receptor blockers.
Burnier M; Kjeldsen SE; Narkiewicz K; Oparil S
Blood Press; 2020 Apr; 29(2):68-69. PubMed ID: 32049554
[No Abstract] [Full Text] [Related]
11. Olmesartan Associated Enteropathy: A Rare Underdiagnosed Cause of Diarrhea and Weight Loss.
Gonakoti S; Khullar S; Rajkumar A
Am J Case Rep; 2019 Jan; 20():111-116. PubMed ID: 30683835
[TBL] [Abstract][Full Text] [Related]
12. A Case of Moderate Sprue-Like Enteropathy Associated With Telmisartan.
Negro A; De Marco L; Cesario V; Santi R; Boni MC; Zanelli M
J Clin Med Res; 2017 Dec; 9(12):1022-1025. PubMed ID: 29163738
[TBL] [Abstract][Full Text] [Related]
13. Olmesartan-Induced Enteropathy: A Report of an Unusual Cause of Chronic Diarrhea.
Sotiropoulos C; Sakka E; Diamantopoulou G; Theocharis GJ; Thomopoulos KC
Cureus; 2021 Aug; 13(8):e17004. PubMed ID: 34540405
[TBL] [Abstract][Full Text] [Related]
14. [Diarrhoea and malabsorption due to olmesartan use].
van Beurden YH; Nijeboer P; Janssen J; Verbeek WH; Mulder CJ
Ned Tijdschr Geneeskd; 2014; 158():A7370. PubMed ID: 24780574
[TBL] [Abstract][Full Text] [Related]
15. [Enteropathy due to olmesartan].
Ould Sidi Mohamed M; Colardelle P
Ann Cardiol Angeiol (Paris); 2016 Apr; 65(2):95-8. PubMed ID: 26067144
[TBL] [Abstract][Full Text] [Related]
16. A Review of Current Evidence of Olmesartan Medoxomil Mimicking Symptoms of Celiac Disease.
Sanford ML; Nagel AK
J Pharm Pract; 2015 Apr; 28(2):189-192. PubMed ID: 24682568
[TBL] [Abstract][Full Text] [Related]
17. Clinical-Pathological Conference Series from the Medical University of Graz: Case No 156: 82-year-old woman with chronic diarrhea and weight loss of 20 kilograms.
Fabian E; Schiller D; Wenzl H; Lackner C; Donnerer J; Ziachehabi A; Silye R; Schöfl R; Krejs GJ
Wien Klin Wochenschr; 2015 Dec; 127(23-24):974-80. PubMed ID: 26610650
[No Abstract] [Full Text] [Related]
18. Olmesartan-Induced Enteropathy.
Adike A; Corral J; Rybnicek D; Sussman D; Shah S; Quigley E
Methodist Debakey Cardiovasc J; 2016; 12(4):230-232. PubMed ID: 28289500
[TBL] [Abstract][Full Text] [Related]
19. Potential coeliac disease markers and autoimmunity in olmesartan induced enteropathy: A population-based study.
Esteve M; Temiño R; Carrasco A; Batista L; Del Val A; Blé M; Santaolaria S; Molina-Infante J; Soriano G; Agudo S; Zabana Y; Andújar X; Aceituno M; Ribes J; Madridejos R; Fernández-Bañares F
Dig Liver Dis; 2016 Feb; 48(2):154-61. PubMed ID: 26699826
[TBL] [Abstract][Full Text] [Related]
20. Severe Sprue-Like Enteropathy and Colitis due to Olmesartan: Lessons Learned From a Rare Entity.
Bashari DR
Gastroenterology Res; 2020 Aug; 13(4):150-154. PubMed ID: 32864026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
